Safety and Performance of PTMC Dermal Filler

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Moderate to Severe Nasolabial Fold
Interventions
DEVICE

PTMC Dermal Filler

A total of 120 subjects will receive treatment with PTMC Dermal Filler. The volume of filler injected will vary depending on the severity of the nasolabial fold. Injections will be administered by the investigator at the beginning of the study, with the injection technique, plane, and volume recorded. Touch-up treatments are permitted at the 1-month follow-up visit, if necessary.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aqpha Medical B.V.

INDUSTRY

NCT06316479 - Safety and Performance of PTMC Dermal Filler | Biotech Hunter | Biotech Hunter